EX1
Pharmaceuticals, Biotechnology & Life Sciences
Exopharm
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 12 Dec 2022
- Reported shorts
- 6.5K
- Shares on issue
- 157.212M
Exopharm (EX1) company profile
Profile, insiders and operations
Company
AI-generated research profile of Exopharm
Biotechnology
Pharmaceuticals
Exosomes
Drug Development
ASX Small Cap
Exopharm Limited is an Australian biopharmaceutical company dedicated to the research, development, and commercialisation of exosomes as a novel class of therapeutic agents. The company leverages its proprietary LEAP (Ligand-based Exosome Affinity Purification) manufacturing technology to enable scalable and high-purity production of exosomes. This positions Exopharm to address significant unmet medical needs across various disease areas by delivering exosome-based medicines.
Director trades
20 trades recorded
EX1 intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required